Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001096906-16-001575
Filing Date
2016-05-03
Accepted
2016-05-02 21:37:40
Documents
6
Period of Report
2016-05-02
Effectiveness Date
2016-05-03

Document Format Files

Seq Description Document Type Size
1 AOXING PHARMACEUTICAL COMPANY, INC. DEF 14A 2016-05-02 aoxing.htm DEF 14A 588408
2 image0.jpg GRAPHIC 5043
3 image1.jpg GRAPHIC 1109
4 image2.jpg GRAPHIC 1571
5 image3.jpg GRAPHIC 1200
6 image4.jpg GRAPHIC 1273
  Complete submission text file 0001096906-16-001575.txt   604429
Mailing Address 1098 FOSTER CITY BLVD. SUITE 106-810 FOSTER CITY CA 94404
Business Address 1098 FOSTER CITY BLVD. SUITE 106-810 FOSTER CITY CA 94404 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-32674 | Film No.: 161613429
SIC: 2834 Pharmaceutical Preparations